| Timothy Richard Moore, MD | |
|
500 W. Fort St., #111, Boise, ID 83702 | |
| (208) 422-1000 | |
| (208) 422-1319 |
| Full Name | Timothy Richard Moore |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 500 W. Fort St., Boise, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124064423 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Richard Moore, MD 500 W Fort St # 111, Boise, ID 83702-4501 Ph: (208) 422-1000 | Timothy Richard Moore, MD 500 W. Fort St., #111, Boise, ID 83702 Ph: (208) 422-1000 |
News Archive
Researchers at one of the top five hospitals in the United States have developed an advanced search tool called the Queriable Patient Inference Dossier (QPID) that helps radiologists and other physicians extract useful data from a patient's electronic medical record (EMR) in a timely and efficient manner, according to an article in the August issue of the Journal of the American College of Radiology.
According to a recent nutrition survey in Australia, 29 percent of the population are taking at least one dietary supplement a day. In the United States, at least 52 percent are taking a dietary supplement a day. The study attempted to look at the long term benefits offered by regular intake of vitamin and mineral supplements for the prevention of diseases such as heart disease and stroke as well as premature death.
For a sixth consecutive year, the American Academy of Neurology (AAN) will be giving away 1,000 bike helmets to children and adults on Saturday, June 17, 2017, at the Mill City Farmers Market.
YM BioSciences Inc., today announced the publication of Phase I results demonstrating that CYT997, a novel vascular disrupting agent (VDA), was well tolerated at doses that were associated with pharmacodynamic evidence of vascular disruption in tumors. The article entitled "Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent," was published in the premier cancer journal, the British Journal of Cancer.
› Verified 6 days ago
Dr. Jennifer A Hofstra, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Road, Boise, ID 83706 Phone: 757-446-8920 Fax: 757-446-5242 | |
Dr. James Robert Polk, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-3104 | |
Dr. Michael Frederic Krug, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 500 W. Fort St, # 111, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1319 | |
Derrel V Walker, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Road, Boise, ID 83706 Phone: 208-367-7350 Fax: 208-367-3951 | |
Dr. Janat E. O'donnell, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 500 W. Fort St., # 111, Boise, ID 83702 Phone: 208-422-1325 Fax: 208-422-1319 | |
Carl L Durning, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 6094 W Emerald St, Boise, ID 83704 Phone: 208-367-6575 Fax: 208-367-6597 | |
Dr. Christopher J Goulet, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6259 W Emerald St, Boise, ID 83704 Phone: 208-489-1900 Fax: 208-375-5286 |